In the body of patients with diabetes, the sodium content increases by an average of 10%, which is accompanied by an increase in extravascular (interstitial and / or intracellular) fluid volume. At the same time, the

Arterial hypertension in diabetic patients exacerbates impaired carbohydrate and lipid metabolism. Thus, hypercholesterolemia, obesity, hyperinsulinemia are registered, respectively, in 85%, 75%, 50% of patients. The presence of these basic disorders increases the risk and accelerates the course

Parts of which are impaired glucose tolerance or type 2 DM, AH, dyslipidemia, and atherosclerosis. Although hyperinsulinemia is a well-known independent risk factor for the development of coronary artery disease and atherosclerosis, it has been

It is known that angiotensin I under the action of dipeptidylcarboxypeptidase, or ACE, is converted into the active octapeptide – angiotensin II. By binding to specific receptors on cell membranes, angiotensin II mediates the main cardiovascular

In recent years, significant progress has been made in studying the genetic factors of hypertension and coronary artery disease. The role of genetic polymorphism in the development of arterial hypertension is widely discussed. Indeed, the

Genetic determination of arterial hypertension in diabetes mellitus is complex and multifactorial, but given the key role in the pathogenesis of arterial hypertension, renin-aldosterone system and endothelial dysfunction, the genes responsible for the synthesis of

Endothelial dysfunction can manifest itself not only by a disorder of its vascular-motor function, but also by disturbances in the hemostatic system. Markers of endothelial dysfunction can be considered an increase in vilbrand factor and thrombomodulin. When

Chymotrypsin-like proteinases in human blood plasma are normally absent and can enter it from granulocytes or damaged tissues, for example, with hereditary hypercholesterolemia, nonspecific aortoarteritis. Stress induces changes associated with an increase in the content of

Angiotensin II is one of the most powerful vasoconstrictors, which determines its role in the pathogenesis of arterial hypertension. Through the receptor AT II type 1 mediated induction of cell growth. The effect of angiotensin